{
    "id": 5216,
    "fullName": "MTOR S2035F",
    "impact": "missense",
    "proteinEffect": "loss of function - predicted",
    "geneVariantDescriptions": [
        {
            "description": "MTOR S2035F lies within the FKBP1A/rapamycin complex-interacting region of the Mtor protein (UniProt.org). S2035F results in the loss of mTOR's ability to bind rapamycin analogs (PMID: 25261369).",
            "references": [
                {
                    "id": 2380,
                    "pubMedId": 25261369,
                    "title": "Catalytic mTOR inhibitors can overcome intrinsic and acquired resistance to allosteric mTOR inhibitors.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/25261369"
                },
                {
                    "id": 295,
                    "pubMedId": null,
                    "title": null,
                    "url": "https://www.uniprot.org"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 2475,
        "geneSymbol": "MTOR",
        "terms": [
            "MTOR",
            "FRAP",
            "FRAP1",
            "FRAP2",
            "RAFT1",
            "RAPT1",
            "SKS"
        ]
    },
    "variant": "S2035F",
    "createDate": "04/23/2015",
    "updateDate": "02/27/2020",
    "referenceTranscriptCoordinates": {
        "id": 145483,
        "transcript": "NM_004958",
        "gDna": "chr1:g.11127736G>A",
        "cDna": "c.6104C>T",
        "protein": "p.S2035F",
        "sourceDb": "RefSeq",
        "refGenomeBuild": "GRCh38/hg38"
    },
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 2076,
            "approvalStatus": "Preclinical",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, Sapanisertib (MLN0128) resulted in growth inhibition of breast cancer cells harboring a rapamycin resistant mutation, MTOR S2035F, in culture and in xenograft models (PMID: 25261369).",
            "molecularProfile": {
                "id": 5030,
                "profileName": "MTOR S2035F"
            },
            "therapy": {
                "id": 1282,
                "therapyName": "Sapanisertib",
                "synonyms": null
            },
            "indication": {
                "id": 1612,
                "name": "breast cancer",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 2380,
                    "pubMedId": 25261369,
                    "title": "Catalytic mTOR inhibitors can overcome intrinsic and acquired resistance to allosteric mTOR inhibitors.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/25261369"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 5030,
            "profileName": "MTOR S2035F",
            "profileTreatmentApproaches": [
                {
                    "id": 4058,
                    "name": "mTOR Inhibitor",
                    "profileName": "MTOR S2035F"
                },
                {
                    "id": 4059,
                    "name": "mTORC2 Inhibitor",
                    "profileName": "MTOR S2035F"
                }
            ]
        }
    ],
    "allTranscriptCoordinates": [
        {
            "id": 145484,
            "transcript": "XM_005263438",
            "gDna": "chr1:g.11127736G>A",
            "cDna": "c.6104C>T",
            "protein": "p.S2035F",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 145483,
            "transcript": "NM_004958",
            "gDna": "chr1:g.11127736G>A",
            "cDna": "c.6104C>T",
            "protein": "p.S2035F",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        }
    ]
}